Vir Biotechnology Inc (NASDAQ: VIR) kicked off on Monday, up 4.49% from the previous trading day, before settling in for the closing price of $7.12. Over the past 52 weeks, VIR has traded in a range of $6.56-$13.09.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 421.39%. While this was happening, its average annual earnings per share was recorded 14.45%. With a float of $87.31 million, this company’s outstanding shares have now reached $134.78 million.
Let’s determine the extent of company efficiency that accounts for 587 employees. In terms of profitability, gross margin is 81.92%, operating margin of -658.31%, and the pretax margin is -685.83%.
Vir Biotechnology Inc (VIR) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 36.61%, while institutional ownership is 49.44%. The most recent insider transaction that took place on Nov 06 ’24, was worth 44,454. In this transaction EVP and General Counsel of this company sold 4,397 shares at a rate of $10.11, taking the stock ownership to the 56,973 shares. Before that another transaction happened on Nov 06 ’24, when Company’s Officer proposed sale 4,397 for $9.64, making the entire transaction worth $42,387.
Vir Biotechnology Inc (VIR) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 14.45% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.00% during the next five years compared to -34.12% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Take a look at Vir Biotechnology Inc’s (VIR) current performance indicators. Last quarter, stock had a quick ratio of 8.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.81 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Looking closely at Vir Biotechnology Inc (NASDAQ: VIR), its last 5-days average volume was 1.57 million, which is a jump from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 19.72%. Additionally, its Average True Range was 0.52.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 19.82%, which indicates a significant decrease from 22.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.96% in the past 14 days, which was higher than the 60.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.90, while its 200-day Moving Average is $9.14. However, in the short run, Vir Biotechnology Inc’s stock first resistance to watch stands at $7.62. Second resistance stands at $7.79. The third major resistance level sits at $8.00. If the price goes on to break the first support level at $7.24, it is likely to go to the next support level at $7.03. Now, if the price goes above the second support level, the third support stands at $6.86.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
The company with the Market Capitalisation of 1.05 billion has total of 137,720K Shares Outstanding. Its annual sales at the moment are 86,180 K in contrast with the sum of -615,060 K annual income. Company’s last quarter sales were recorded 2,380 K and last quarter income was -213,720 K.
